Perbak Capital Partners LLP Amgen Inc Transaction History
Perbak Capital Partners LLP
- $338 Billion
- Q2 2024
A detailed history of Perbak Capital Partners LLP transactions in Amgen Inc stock. As of the latest transaction made, Perbak Capital Partners LLP holds 3,050 shares of AMGN stock, worth $981,459. This represents 0.28% of its overall portfolio holdings.
Number of Shares
3,050Holding current value
$981,459% of portfolio
0.28%Shares
1 transactions
Others Institutions Holding AMGN
# of Institutions
3,085Shares Held
417MCall Options Held
7.19MPut Options Held
6.11M-
Vanguard Group Inc Valley Forge, PA51.9MShares$16.7 Billion0.32% of portfolio
-
Black Rock Inc. New York, NY46MShares$14.8 Billion0.33% of portfolio
-
State Street Corp Boston, MA29MShares$9.32 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA14.4MShares$4.65 Billion3.32% of portfolio
-
Morgan Stanley New York, NY14.4MShares$4.62 Billion0.35% of portfolio
About AMGEN INC
- Ticker AMGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 534,931,008
- Market Cap $172B
- Description
- Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...